CAS RN: 1448525-91-4
S55746 (BCL-201)
Product Availability
Choose a grade to view its available package options.
7 package records6 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250506 |
5mg / 10mg |
Out of stock |
| 15 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250312 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250615 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251106 |
250mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250514 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250925 |
50mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250903 |
5mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS1448525-91-4
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1448525-91-4 / N-(4-hydroxyphenyl)-3-[6-[(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]-1,3-benzodioxol-5-yl]-N-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide;hydrochloride
Standard CAS: 1448525-91-4
Multi CAS: No
Basic Information
CAS
1448525-91-4
Multi CAS
No
Molecular Formula
C43H43ClN4O6
Molecular Weight
747.300000
Exact Mass
746.287113
SMILES
C1CCN2C(=C(C=C2C3=CC4=C(C=C3C(=O)N5CC6=CC=CC=C6C[C@H]5CN7CCOCC7)OCO4)C(=O)N(C8=CC=CC=C8)C9=CC=C(C=C9)O)C1.Cl
InChI
InChI=1S/C43H42N4O6.ClH/c48-34-15-13-32(14-16-34)47(31-10-2-1-3-11-31)43(50)37-23-39(45-17-7-6-12-38(37)45)35-24-40-41(53-28-52-40)25-36(35)42(49)46-26-30-9-5-4-8-29(30)22-33(46)27-44-18-20-51-21-19-44;/h1-5,8-11,13-16,23-25,33,48H,6-7,12,17-22,26-28H2;1H/t33-;/m0./s1
InChIKey
RAUZIGXCAJHBEL-WAQYZQTGSA-N
Computed Properties
Structural Parameters
Heavy atom count
54
Aromatic heavy atom count
29
Fraction Csp3
0.3
Rotatable bonds
7
H-bond acceptors
8
H-bond donors
1
Molar refractivity
208.26
TPSA
96.71
LogP / Solubility
WLOGP
7.23
MLOGP
6.42
XLogP3
7.23
Consensus LogP
6.96
Log S (ESOL)
-8.96
Class (ESOL)
Insoluble
Log S (Ali)
-10.9
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-11.35
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.15
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
7.5